Navigation Links
GeneChoice TEMPase II DNA Polymerase from GeneChoice, Inc.

ProductsGeneChoice TEMPase II DNA Polymerase from GeneChoice, Inc.
Company GeneChoice, Inc.
Item GeneChoice TEMPase II DNA Polymerase
Price $220.00
Description • Heat activated
• Eliminates nonspecific products due to inactivity at room temperature
• Excellent specificity allows extension through DNA regions which contain repeats and secondary structures
• Leaves an 'A' overhang

TEMPase II is a chemically modified form of GeneChoice DNA Polymerase that remains inactive at room temperature and works optimally in a distinctive buffer system.

TEMPase II is useful for performing automated hot start amplification due to its thermal activation at a temperature well above optimal annealing. The enzyme remains inactive until the time, temperature, and pH are optimal. During hot start, primers bind only to their specific target, and polymerase activity is directed exclusively to that target. As a result, only the region of interest is amplified, which increases sensitivity and yield while reducing non-specific background amplification.

Once the reaction reaches optimal annealing temperatures after a 15 minute activation step at 95C, the enzyme stays activated in the reaction.

Since the enzyme is chemically modified for hot start (no antibody), there is no material from animal sources, i.e., there is no possibility for biological contamination.

10X TEMPase II Reaction Buffer - Combination of (NH4)2S04 and KCl, 15 mM MgCl2, 1% Tween 20.
25 mM MgCl2 Solution - Supplied.
Info GeneChoice, Inc.GeneChoice, Inc.
7307 Governors Way
Frederick, MD 21703 USA

Call GeneChoice, Inc. to buy products (US and Canada only; other locations use numbers below)
USA Canada 1-866-772-8354
Customer Service: 866-636-2200
Fax Number: 301-620-0162
Web Site: http://www.genechoiceinc.com
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. GeneChoice Taq DNA Polymerase With Standard Buffer from GeneChoice, Inc.
2. GeneChoice Taq DNA Polymerase With Ammonium Buffer from GeneChoice, Inc.
3. GeneChoice Taq DNA Polymerase With Magnesium Free Standard Buffer from GeneChoice, Inc.
4. GeneChoice RNA Safe Recombinant Ribonuclease Inhibitor from GeneChoice, Inc.
5. T4 DNA Polymerase from Roche Applied Science
6. T4 DNA Polymerase from Roche Applied Science
7. Poly A Polymerase from Invitrogen
8. iTaq DNA Polymerase, 250 U from Bio-Rad
9. iTaq DNA Polymerase, 5,000 U from Bio-Rad
10. Taq DNA Polymerase, 500 U (2 x 250 U) without dNTP from Bioneer, Inc.
11. T4 DNA Polymerase from Invitrogen
(Date:1/4/2017)... 2017  For the thousands of attendees at this year,s International Consumer ... health and biometric measurement devices and services, will be featuring its new ... in A&D Medical,s special CES Exhibit Suite , the new upper ... the company,s WellnessConnected product platform.  ... ...
(Date:1/3/2017)... Jan. 3, 2017 Onitor, provider of digital ... Onitor Track, an innovative biometric data-driven program designed to ... month at the 2017 Consumer Electronics Show (CES) in ... In the U.S., the World Health Organization (WHO), have ... of adults who are overweight or obese. WHO also ...
(Date:12/22/2016)... , December 22, 2016 SuperCom ... of secure solutions for the e-Government, Public Safety, HealthCare, and Finance ... of SuperCom, has been selected to implement and deploy a community-based ... Northern California , further expanding its presence in ... This ...
Breaking Biology News(10 mins):
(Date:1/13/2017)... ... 13, 2017 , ... FireflySci has been busy rolling out ... diverse customer base. The latest entry in this field is a series of ... Bio-Rad. FireflySci is introducing three distinct varieties including a 10x1mm, 10x2 and 10x4 ...
(Date:1/12/2017)... , ... January 12, 2017 ... ... devices with short response times capable of performing routine electrochemical biosensing has ... screen-printed electrodes provide fast, sensitive detection and quantification of various analytes in ...
(Date:1/12/2017)... Jan. 12, 2017   Protein Sciences Corporation ... of Flublok Influenza Vaccine ®, announced today ... had good safety results and induced strong neutralizing ... The product is expected to advance into human ... addition, the Institute of Technology in Immunobiologicals of ...
(Date:1/11/2017)... ... January 11, 2017 , ... Phase 1 clinical trial data ... the investigational anti-cancer agent tucatinib (formerly ONT-380) against HER2+ breast cancer. The 50 ... of these heavily pretreated patients saw clinical benefit from the drug, with at ...
Breaking Biology Technology: